Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy Publisher Pubmed

Hashemi V^{1, 2} ; Farhadi S³ ; Ghasemi Chaleshtari M⁴ ; Seashoreludlow B⁵ ; Masjedi A⁶ ; Hojjatfarsangi M^{7, 8} ; Namdar A⁹ ; Ajjoolabady A⁴ ; Mohammadi H¹⁰ ; Ghalamfarsa G¹¹ ; Jadidiniaragh F^{12, 13}

Source: International Immunopharmacology Published:2020

Abstract

Dendritic cell (DC)-based cancer immunotherapy has shown impressive outcomes, including the development of the first FDA-approved anti-cancer vaccine. However, the clinical application of DC-based cancer immunotherapy is associated with various challenges. Promising novel tools for the administration of cancer vaccines has emerged from recent developments in nanoscale biomaterials. One current strategy to enhance targeted drug delivery, while minimizing drug-related toxicities, is the use of nanoparticles (NPs). These can be utilized for antigen delivery into DCs, which have been shown to provide potent T cell-stimulating effects. Therefore, NP delivery represents one promising approach for creating an effective and stable immune response without toxic side effects. The current review surveys cancer immunotherapy with particular attention toward NP-based delivery methods that target DCs. © 2020

Related Docs

View other Related Docs

1. Concomitant Blockade of A2ar and Ctla-4 by Sirna-Loaded Polyethylene Glycol-Chitosan-Alginate Nanoparticles Synergistically Enhances Antitumor T-Cell Responses, Journal of Cellular Physiology (2020)

2. Nanoparticles in Cancer Immunotherapies: An Innovative Strategy, Biotechnology Progress (2021)

3. Blockade of Ctla-4 Increases Anti-Tumor Response Inducing Potential of Dendritic Cell Vaccine, Journal of Controlled Release (2020)

Experts (# of related papers)

View all Related Experts

Fatemeh Atyabi (15)

Ziba Veisi Malekshahi (1)

Other Related Docs

4. Silencing of Hif-1Α/Cd73 Axis by Sirna-Loaded Tat-Chitosan-Spion Nanoparticles Robustly Blocks Cancer Cell Progression, European Journal of Pharmacology (2020)

5. Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy, Nanomedicine: Nanotechnology# Biology# and Medicine (2020)

6. Inhibition of Cd73 Using Folate Targeted Nanoparticles Carrying Anti-Cd73 Sirna Potentiates Anticancer Efficacy of Dinaciclib, Life Sciences (2020)

7. Silencing of Il-6 and Stat3 by Sirna Loaded Hyaluronate-N,N,N-Trimethyl Chitosan Nanoparticles Potently Reduces Cancer Cell Progression, International Journal of Biological Macromolecules (2020)

8. Blockage of Immune Checkpoint Molecules Increases T-Cell Priming Potential of Dendritic Cell Vaccine, Immunology (2020)

9. Coinhibition of S1pr1 and Gp130 by Sirna-Loaded Alginate-Conjugated Trimethyl Chitosan Nanoparticles Robustly Blocks Development of Cancer Cells, Journal of Cellular Physiology (2020)

10. Silencing of P68 and Stat3 Synergistically Diminishes Cancer Progression, Life Sciences (2020)

11. Simultaneous Inhibition of Cd73 and Il-6 Molecules by Sirna-Loaded Nanoparticles Prevents the Growth and Spread of Cancer, Nanomedicine: Nanotechnology# Biology# and Medicine (2021)

12. Combined Inhibition of Cd73 and Zeb1 by Arg-Gly-Asp (Rgd)-Targeted Nanoparticles Inhibits Tumor Growth, Colloids and Surfaces B: Biointerfaces (2021)

13. Regulatory T Cells in Breast Cancer As a Potent Anti-Cancer Therapeutic Target, International Immunopharmacology (2020)

14. Downregulation of A2ar by Sirna Loaded Peg-Chitosan-Lactate Nanoparticles Restores the T Cell Mediated Anti-Tumor Responses Through Blockage of Pka/Creb Signaling Pathway, International Journal of Biological Macromolecules (2019)

15. Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response, Pharmaceutical Research (2022)

16. Inhibition of Hif-1Α/Ep4 Axis by Hyaluronate-Trimethyl Chitosan-Spion Nanoparticles Markedly Suppresses the Growth and Development of Cancer Cells, International Journal of Biological Macromolecules (2021)

17. Hypoxia Inducible Factors in the Tumor Microenvironment As Therapeutic Targets of Cancer Stem Cells, Life Sciences (2019)

18. Downregulation of Cd73 in 4T1 Breast Cancer Cells Through Sirna-Loaded Chitosan-Lactate Nanoparticles, Tumor Biology (2016)

19. Polymeric Nanoparticles for Dna Vaccine-Based Cancer Immunotherapy: A Review, Biotechnology Letters (2023)

20. Codelivery of Stat3 Sirna and Bv6 by Carboxymethyl Dextran Trimethyl Chitosan Nanoparticles Suppresses Cancer Cell Progression, International Journal of Pharmaceutics (2020)

Style	Citing Format
MLA	Hashemi V, et al.. "Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy." International Immunopharmacology, vol. 83, no. , 2020, pp. -.
APA	Hashemi V, Farhadi S, Ghasemi Chaleshtari M, Seashoreludlow B, Masjedi A, Hojjatfarsangi M, Namdar A, Ajjoolabady A, Mohammadi H, Ghalamfarsa G, Jadidiniaragh F (2020). Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy. International Immunopharmacology, 83(), -.
Chicago	Hashemi V, Farhadi S, Ghasemi Chaleshtari M, Seashoreludlow B, Masjedi A, Hojjatfarsangi M, Namdar A, et al.. "Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy." International Immunopharmacology 83, no. (2020): -.
Harvard	Hashemi V et al. (2020) 'Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy', International Immunopharmacology, 83(), pp. -.
Vancouver	Hashemi V, Farhadi S, Ghasemi Chaleshtari M, Seashoreludlow B, Masjedi A, Hojjatfarsangi M, et al.. Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy. International Immunopharmacology. 2020;83():-.
BibTex	@article{ author = {Hashemi V and Farhadi S and Ghasemi Chaleshtari M and Seashoreludlow B and Masjedi A and Hojjatfarsangi M and Namdar A and Ajjoolabady A and Mohammadi H and Ghalamfarsa G and Jadidiniaragh F}, title = {Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy}, journal = {International Immunopharmacology}, volume = {83}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Hashemi V AU - Farhadi S AU - Ghasemi Chaleshtari M AU - Seashoreludlow B AU - Masjedi A AU - Hojjatfarsangi M AU - Namdar A AU - Ajjoolabady A AU - Mohammadi H AU - Ghalamfarsa G AU - Jadidiniaragh F TI - Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy JO - International Immunopharmacology VL - 83 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract